Pay in 4 interest-free payments of $115.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
consult a healthcare provider promptly
Follow nitrate-free intervals if prescribed
Lower-dose option for better tolerability
Do not crush or chew the tablets to ensure proper release and absorption
Users preferring chewable or soft tablet formulations
Revolade 50 mg (Eltrombopag) (Generic) Ovulation Induction Injection consult a healthcare provider promptlyProduct Overview Revolade 50 mg (Eltrombopag) is a prescription medication manufactured by GlaxoSmithKline Pharmaceuticals Ltd, specifically formulated to treat thrombocytopenia, or low platelet counts, associated with immune thrombocytopenic purpura (ITP) and chronic hepatitis C virus (HCV) infection. Supplied in convenient packaging of 7 tablets per strip, each tablet contains 50 mg of the active ingredient eltrombopag. What is Revolade 50 mg
